Back from ASH 2025, Dr Suchitra Sundaram reports on notable frontline CLL data. Time‑limited pirtobrutinib combined with venetoclax and obinutuzumab produced high rates of undetectable minimal ...
Large language models (LLMs) are rapidly being integrated into clinical workflows, supporting tasks such as diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results